SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia

Overview of attention for article published in British Journal of Haematology, July 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 57 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 25,773 followers.

British Journal of Haematology。再発急性骨髄性白血病に対するイダルビシン・シタラビンと大量プラバスタチンの第2相試験。プラバスタチン1280mg内服8日間って一体何錠のんだんだろう？？ http://t.co/vLR62j76hd

SWOG0919: A Phase II Study of Idarubicin and Cytarabine in Combination with Pravastatin for Relapsed AML http://t.co/6hPvsFvZ4q

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.